查看购物车
  • Traditional Chinese
  • English
2021-2031 年亚太地区输液设备市场报告（范围、细分、动态和竞争分析）
市场调查报告书
商品编码
1843392

2021-2031 年亚太地区输液设备市场报告（范围、细分、动态和竞争分析）

Asia Pacific Infusion Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 192 Pages | 订单完成后即时交付

价格

亚太输液设备市场预计将大幅成长，到 2031 年将达到约 54.9048 亿美元，高于 2023 年的 30.142 亿美元，在 2023 年至 2031 年的预测期内，年复合成长率(CAGR) 为 7.8%。

执行摘要和市场分析

亚太地区（包括中国、日本、印度、澳洲、韩国等国家）的输液设备市场正在快速成长。这一成长受到多种因素的推动，包括越来越多的市场参与者推出创新且经济高效的产品、地方政府的支持倡议，以及癌症和糖尿病等慢性病发病率的上升。本地製造商的存在也提高了该地区输液设备的可近性。

市场区隔

亚太输液设备市场可根据产品类型、应用和最终用户进行细分。

1. 产品类型：市场分为输液帮浦和输液器。 2023年，输液帮浦占据了市场份额的主导地位。输液泵的细分市场包括容积泵、注射泵、胰岛素泵、患者自控镇痛 (PCA) 泵、肠内泵、植入式泵和弹性泵，其中容积泵占最大份额。输液器分为排气式和非排气式，其中排气式输液器市占率最高。

2. 应用：市场根据应用进一步细分为糖尿病、肿瘤学、疼痛管理、血液学、儿科、胃肠病学等。糖尿病应用在2023年占据了最大的市场。

3. 最终用户：输液设备的最终用户包括医院和专科诊所、家庭护理机构、门诊手术中心等，其中医院和专科诊所将在 2023 年占据最大的份额。

市场展望

亚太输液设备市场的主要参与者正专注于产品发布、併购和合作等策略性倡议，以增强其针对糖尿病、癌症和慢性疼痛等慢性疾病的产品服务。近期进展包括：

  • 2023 年 2 月，迈瑞推出了 BeneFusion i 系列和 u 系列输液系统，旨在在各种临床环境中实现高精度和安全的药物输送。
  • 2022 年 3 月，费森尤斯卡比 (Fresenius Kabi) 的 Agilia Connect 输液系统获得 FDA 批准，该系统包括配备 Vigilant Software Suite 技术的先进容量泵和注射泵。
  • Eitan Medical 于 2021 年 1 月在英国开展业务，以更好地支援其 Sapphire 输液帮浦客户，包括 NHS Trusts 和私人医疗保健提供者。

这些进步显示产品审批和策略伙伴关係呈现成长趋势，预计将为输液设备市场创造重大机会。

国家洞察

亚太输液设备市场受各国具体动态的影响显着。中国在2023年成为最大的市场。例如，2021年10月，EOFlow有限公司与长沙三诺生物科技有限公司成立合资企业，以进军不断扩大的中国糖尿病市场，专注于生产和分销可穿戴胰岛素帮浦EOPatch。此外，中国在2023年进口了超过200万台输液泵，价值23.5万美元，位居全球第二大输液泵进口国。需要输液治疗的慢性病盛行率不断上升，这推动了中国市场的成长。

公司简介

亚太地区输液设备市场的主要参与者包括B Braun SE、百特国际公司 (Baxter International Inc)、Becton Dickinson and Co、BPL Medical Technologies Pvt Ltd、CODAN US Corp、Eitan Medical Ltd、Elimedical Inc、Fresenius Kabi AG、ICU Medical Technologies Inc、KD Scientific Inc、美敦力公司 (prodic Plc Inc. Corp)、Polymedicure、Tandem Diabetes Care Inc、泰尔茂公司 (Terumo Corp) 和 Zimed Healthcare Ltd 等。这些公司正在积极推行市场扩张、产品创新和併购等策略，以提升市场占有率并为消费者提供创新解决方案。

目录

第一章：简介

第二章：执行摘要

  • 关键见解

第三章：研究方法

  • 二次研究
  • 初步研究
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第四章：亚太输液设备市场格局

  • PEST分析

第五章：亚太输液设备市场－主要市场动态

  • 亚太输液设备市场－主要市场动态
  • 市场驱动因素
    • 癌症发生率不断上升
    • 老年人口不断增加
  • 市场限制
    • 输液设备频繁召回
  • 市场机会
    • 市场参与者的策略性倡议
  • 未来趋势
    • 不断进步的技术
  • 驱动因素和限制因素的影响：

第六章：亚太输液设备市场 - 分析

  • 2021-2031年亚太地区输液设备市场收入
  • 亚太输液设备市场预测分析

第七章：亚太输液设备市场分析－依产品类型

  • 点滴帮浦
  • 点滴器

第八章：亚太输液设备市场分析－依应用

  • 糖尿病
  • 肿瘤学
  • 疼痛管理
  • 血液学
  • 儿科
  • 胃肠病学
  • 其他的

第九章：亚太输液设备市场分析－按最终用户

  • 医院和专科诊所
  • 家庭护理设置
  • 门诊手术中心
  • 其他的

第 10 章：亚太输液设备市场 - 国家分析

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区

第 11 章：产业格局

  • 概述
  • 输液设备市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第十二章：公司简介

  • Becton Dickinson and Co
  • Fresenius Kabi AG
  • B Braun SE
  • CODAN US Corp
  • Baxter International Inc
  • Elimedical Inc
  • ICU Medical Inc
  • BPL Medical Technologies Pvt Ltd
  • Nipro Corp
  • KD Scientific Inc
  • Medtronic Plc
  • Zimed Healthcare Ltd
  • Terumo Corp
  • Eitan Medical Ltd
  • Polymedicure
  • Moog Inc
  • Tandem Diabetes Care Inc

第 13 章：附录

Product Code: BMIRE00032020

The Asia Pacific infusion devices market is projected to grow significantly, reaching approximately US$ 5,490.48 million by 2031, up from US$ 3,014.20 million in 2023, reflecting a compound annual growth rate (CAGR) of 7.8% during the forecast period from 2023 to 2031.

Executive Summary and Market Analysis

The Asia Pacific region, which includes countries such as China, Japan, India, Australia, South Korea, and others, is experiencing rapid growth in the infusion devices market. This growth is driven by several factors, including the increasing number of market players introducing innovative and cost-effective products, supportive initiatives from local governments, and a rising incidence of chronic diseases like cancer and diabetes. The presence of local manufacturers also enhances the accessibility of infusion devices across the region.

Market Segmentation

The Asia Pacific infusion devices market can be segmented based on product type, application, and end user.

1. Product Type: The market is divided into infusion pumps and infusion sets. In 2023, infusion pumps dominated the market share. Within infusion pumps, the segments include volumetric pumps, syringe pumps, insulin pumps, patient-controlled analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps, with volumetric pumps holding the largest share. Infusion sets are categorized into vented and non-vented sets, with vented sets leading in market share.

2. Application: The market is further segmented by application into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others. Diabetes applications accounted for the largest market share in 2023.

3. End User: The end users of infusion devices include hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others, with hospitals and specialty clinics representing the largest segment in 2023.

Market Outlook

Key players in the Asia Pacific infusion devices market are focusing on strategic initiatives such as product launches, mergers, acquisitions, and collaborations to enhance their offerings for chronic conditions like diabetes, cancer, and chronic pain. Recent developments include:

  • In February 2023, Mindray introduced the BeneFusion i Series and u Series infusion systems, designed for high precision and safety in medication delivery across various clinical environments.
  • In March 2022, Fresenius Kabi received FDA clearance for its Agilia Connect Infusion System, which includes advanced volumetric and syringe pumps equipped with Vigilant Software Suite technology.
  • Eitan Medical launched operations in the UK in January 2021 to better support its Sapphire infusion pump customers, including NHS Trusts and private healthcare providers.

These advancements indicate a growing trend of product approvals and strategic partnerships, which are expected to create significant opportunities in the infusion devices market.

Country Insights

The Asia Pacific infusion devices market is notably influenced by country-specific dynamics. China emerged as the largest market in 2023. For instance, in October 2021, EOFlow Co., Ltd. established a joint venture with Changsha Sinocare Co., Ltd. to penetrate the expanding Chinese diabetes market, focusing on the production and distribution of the EOPatch, a wearable insulin pump. Additionally, China imported over 2 million infusion pumps valued at US$ 0.235 million in 2023, ranking second among the top importers of infusion pumps. The increasing prevalence of chronic diseases necessitating infusion therapies is propelling market growth in China.

Company Profiles

Key players in the Asia Pacific infusion devices market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd, among others. These companies are actively pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their market presence and deliver innovative solutions to consumers.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. Asia Pacific Infusion Devices Market Landscape

  • 4.1 PEST Analysis

5. Asia Pacific Infusion Devices Market - Key Market Dynamics

  • 5.1 Asia Pacific Infusion Devices Market - Key Market Dynamics
  • 5.2 Market Drivers
    • 5.2.1 Increasing Prevalence of Cancer
    • 5.2.2 Growing Geriatric Population
  • 5.3 Market Restraints
    • 5.3.1 Frequent Product Recalls of Infusion Devices
  • 5.4 Market Opportunities
    • 5.4.1 Strategic Initiatives by Market Players
  • 5.5 Future Trends
    • 5.5.1 Growing Technological Advancements
  • 5.6 Impact of Drivers and Restraints:

6. Asia Pacific Infusion Devices Market - Analysis

  • 6.1 Asia Pacific Infusion Devices Market Revenue (US$ Million), 2021-2031
  • 6.2 Asia Pacific Infusion Devices Market Forecast Analysis

7. Asia Pacific Infusion Devices Market Analysis - by Product Type

  • 7.1 Infusion Pumps
    • 7.1.1 Overview
    • 7.1.2 Infusion Pumps: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Infusion Sets
    • 7.2.1 Overview
    • 7.2.2 Infusion Sets: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Infusion Devices Market Analysis - by Application

  • 8.1 Diabetes
    • 8.1.1 Overview
    • 8.1.2 Diabetes: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Oncology
    • 8.2.1 Overview
    • 8.2.2 Oncology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Pain Management
    • 8.3.1 Overview
    • 8.3.2 Pain Management: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.4 Hematology
    • 8.4.1 Overview
    • 8.4.2 Hematology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.5 Pediatrics
    • 8.5.1 Overview
    • 8.5.2 Pediatrics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.6 Gastroenterology
    • 8.6.1 Overview
    • 8.6.2 Gastroenterology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Infusion Devices Market Analysis - by End User

  • 9.1 Hospitals and Specialty Clinics
    • 9.1.1 Overview
    • 9.1.2 Hospitals and Specialty Clinics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.2 Homecare Settings
    • 9.2.1 Overview
    • 9.2.2 Homecare Settings: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.3 Ambulatory Surgical Centers
    • 9.3.1 Overview
    • 9.3.2 Ambulatory Surgical Centers: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 9.4 Others
    • 9.4.1 Overview
    • 9.4.2 Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Asia Pacific Infusion Devices Market - Country Analysis

  • 10.1 Asia Pacific
    • 10.1.1 Asia Pacific Infusion Devices Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.1 Asia Pacific Infusion Devices Market - Revenue and Forecast Analysis - by Country
      • 10.1.1.2 China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.2.1 China: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.2.2 China: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.2.3 China: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.2.4 China: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.2.5 China: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.3 Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.3.1 Japan: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.3.2 Japan: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.3.3 Japan: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.3.4 Japan: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.3.5 Japan: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.4 India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.4.1 India: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.4.2 India: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.4.3 India: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.4.4 India: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.4.5 India: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.5 Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.5.1 Australia: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.5.2 Australia: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.5.3 Australia: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.5.4 Australia: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.5.5 Australia: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.6 South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.6.1 South Korea: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.6.2 South Korea: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.6.3 South Korea: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.6.4 South Korea: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.6.5 South Korea: Asia Pacific Infusion Devices Market Share - by End User
      • 10.1.1.7 Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 10.1.1.7.1 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Product Type
        • 10.1.1.7.2 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Infusion Pumps
        • 10.1.1.7.3 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Infusion Sets
        • 10.1.1.7.4 Rest of APAC: Asia Pacific Infusion Devices Market Share - by Application
        • 10.1.1.7.5 Rest of APAC: Asia Pacific Infusion Devices Market Share - by End User

11. Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in Infusion Devices Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Becton Dickinson and Co
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Fresenius Kabi AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 B Braun SE
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 CODAN US Corp
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Baxter International Inc
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Elimedical Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 ICU Medical Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 BPL Medical Technologies Pvt Ltd
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Nipro Corp
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 KD Scientific Inc
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments
  • 12.11 Medtronic Plc
    • 12.11.1 Key Facts
    • 12.11.2 Business Description
    • 12.11.3 Products and Services
    • 12.11.4 Financial Overview
    • 12.11.5 SWOT Analysis
    • 12.11.6 Key Developments
  • 12.12 Zimed Healthcare Ltd
    • 12.12.1 Key Facts
    • 12.12.2 Business Description
    • 12.12.3 Products and Services
    • 12.12.4 Financial Overview
    • 12.12.5 SWOT Analysis
    • 12.12.6 Key Developments
  • 12.13 Terumo Corp
    • 12.13.1 Key Facts
    • 12.13.2 Business Description
    • 12.13.3 Products and Services
    • 12.13.4 Financial Overview
    • 12.13.5 SWOT Analysis
    • 12.13.6 Key Developments
  • 12.14 Eitan Medical Ltd
    • 12.14.1 Key Facts
    • 12.14.2 Business Description
    • 12.14.3 Products and Services
    • 12.14.4 Financial Overview
    • 12.14.5 SWOT Analysis
    • 12.14.6 Key Developments
  • 12.15 Polymedicure
    • 12.15.1 Key Facts
    • 12.15.2 Business Description
    • 12.15.3 Financial Overview
    • 12.15.4 SWOT Analysis
    • 12.15.5 Key Developments
  • 12.16 Moog Inc
    • 12.16.1 Key Facts
    • 12.16.2 Business Description
    • 12.16.3 Products and Services
    • 12.16.4 Financial Overview
    • 12.16.5 SWOT Analysis
    • 12.16.6 Key Developments
  • 12.17 Tandem Diabetes Care Inc
    • 12.17.1 Key Facts
    • 12.17.2 Business Description
    • 12.17.3 Products and Services
    • 12.17.4 Financial Overview
    • 12.17.5 SWOT Analysis
    • 12.17.6 Key Developments

13. Appendix

  • 13.1 About The Insight Partners

List Of Tables

  • Table 1. Asia Pacific Infusion Devices Market Segmentation
  • Table 2. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Product Type
  • Table 4. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Application
  • Table 5. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by End User
  • Table 6. Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 8. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 9. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 10. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 11. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 12. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 13. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 14. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 15. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 16. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 17. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 18. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 19. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 20. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 21. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 22. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 23. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 24. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 25. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 26. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 27. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 28. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 29. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 30. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 31. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 32. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Product Type
  • Table 33. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Pumps
  • Table 34. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Infusion Sets
  • Table 35. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
  • Table 36. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
  • Table 37. Recent Organic Growth Strategies in Infusion Devices Market
  • Table 38. Recent Inorganic Growth Strategies in the Infusion Devices Market

List Of Figures

  • Figure 1. Asia Pacific Infusion Devices Market Segmentation - Country
  • Figure 2. PEST Analysis
  • Figure 1. Global Incidence of Cancer, 2022
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Asia Pacific Infusion Devices Market Revenue (US$ Million), 2021-2031
  • Figure 4. Asia Pacific Infusion Devices Market Share (%) - by Product Type (2023 and 2031)
  • Figure 5. Infusion Pumps: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 6. Infusion Sets: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Asia Pacific Infusion Devices Market Share (%) - by Application (2023 and 2031)
  • Figure 8. Diabetes: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. Oncology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Pain Management: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Hematology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Pediatrics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 13. Gastroenterology: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Asia Pacific Infusion Devices Market Share (%) - by End User (2023 and 2031)
  • Figure 16. Hospitals and Specialty Clinics: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Homecare Settings: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 18. Ambulatory Surgical Centers: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Others: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Asia Pacific Infusion Devices Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. China: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 22. Japan: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. India: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. Australia: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. South Korea: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. Rest of APAC: Asia Pacific Infusion Devices Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Growth Strategies in Infusion Devices Market